Company: MBIO
Filing Date: 2025-02-11
Form Type: 8-K
Source: 0001104659-25-011517
Chunk: 2

Company: MUSTANG BIO, INC.
Filing Date: 2025-02-11
Form: 8-K
Item: Item 1.01
Chunk 2
---
 aggregate gross proceeds raised in the
Offering, (ii) a management fee equal to 1.0% of the aggregate gross proceeds raised in the Offering, (iii) up to $100,000 for fees and
expenses of the Placement Agent’s counsel and other out of pocket expenses, (iv) a non-accountable expense allowance of $25,000,
(v) up to $3,500 for road show expenses, and (vi) $15,950 for the clearing expenses.

Also pursuant to
the Engagement Letter, the Company, in connection with the Offering, agreed to issue to the Placement Agent or its designees
warrants (the “ Placement Agent Warrants”) to purchase up to an aggregate of 159,468 shares of common stock (the
“ Placement Agent Warrant Shares”) (which represents 6.0% of the Shares and Pre-Funded Warrants sold in the Offering).
The Placement Agent Warrants will become exercisable beginning on the effective date of the Warrant Stockholder Approval, have an
exercise price of $3.7625 (125% of the combined public offering price per share of common stock and accompanying Warrants) and will
terminate on the five-year anniversary of commencement of sales in the Offering.

The Shares, the Pre-Funded
Warrants, the Pre-Funded Warrant Shares, the Series C-1 Warrants, the Series C-1 Warrant Shares, Series C-2 Warrants, the Series C-2 Warrant
Shares, the Placement Agent Warrants and the Placement Agent Warrant Shares were offered by the Company pursuant to a Registration Statement
on Form S-1 originally filed on January 15, 2025, as amended (including the prospectus forming a part of such Registration Statement),
with the Securities and Exchange Commission (the “ SEC”) under the Securities Act (File No. 333-284299), and declared effective
by the SEC on February 5, 2025.